EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The effect of time to nephrectomy on cancer‐specific mortality in pathological T stage ( pT)1b –2 renal cancer

Michele Nicolazzini iD, Federico Polverino iD, Leonardo Quarta iD, Maximilian Filzmayer iD, Michele Petix iD, Calogero Catanzaro iD, Nick Lee iD, Jordan A Goyal iD, Nicola Longo iD, Gennaro Musi, Felix K H Chun iD, Alberto Briganti und 6 weitere

BJU International · 2026-12 · 138 (6) · 1160-1170

DOI: 10.1111/bju.70468 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJU International, online erschienen am 29.09.2026. Verfasst von Michele Nicolazzini und 17 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada. Hauptthemen laut MEDLINE: Nephrectomy, Kidney Neoplasms, Carcinoma, Renal Cell, Time-to-Treatment. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To assess the impact of prolonged time to surgery on cancer‐specific mortality (CSM) in patients with pathological T stage (pT)1b–2 N0M0 renal cell carcinoma (RCC) treated with nephrectomy (either partial [PN] or radical [RN]). Within the Surveillance, Epidemiology and End Results (SEER) database (2004–2021), we tested the effect of time to surgery >3 vs ≤3 months on CSM in patients with pT1b‐2N0M0 RCC. Patients and Methods Propensity score matching (PSM) and multivariable competing risks regression (CRR) were performed. Subgroup analyses stratified patients according to time to surgery interval (≤1 vs 1–3 months, ≤3 vs 3–6 months, ≤3 vs >6 months), histotype, and grade.

Results

Of 16 322 patients with pT1b–2 RCC treated with nephrectomy, time to surgery >3 months was recorded in 3023 (18%) patients. These patients were older (median age 64 vs 62 years) and harboured a smaller proportion of pT2 patients (19% vs 30%). After one‐to‐one PSM, 3023 (100%) patients with a time to surgery >3 months exhibited a 60‐month CSM of 7.6% vs 5.9% in 3023 (23%) patients with a time to surgery ≤3 months. In CRR time to surgery >3 months independently predicted 1.3‐fold higher CSM ( P = 0.02). Subgroup analyses revealed a dose–response effect, with a CSM increase in 1.3‐fold fashion when time to surgery was 3–6 months vs 1.6‐fold fashion when time to surgery was >6 months. The detrimental effect of time to surgery>3 months was consistent across all grades but was not evidenced among patients with a non‐clear cell RCC.

Conclusion

In patients with pT1b‐2N0M0 treated with either PN or RN, prolonged time from diagnosis to surgery was associated with higher CSM. This association was not observed among patients with non‐clear cell RCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NephrectomyKidney NeoplasmsCarcinoma, Renal CellTime-to-TreatmentHumansFemaleMiddle AgedNeoplasm StagingMaleAgedSEER ProgramTreatment DelayTime FactorsPropensity Score

Stichwörter der Autor:innen

Surveillance, Epidemiology and End Results (SEER)kidney cancernephrectomyrenal cell carcinomasurgical delay

Autor:innen und Institutionen

  • Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.
  • Division of Urology, Department of Translational Medicine, Maggiore della Carità Hospital, University of Eastern Piedmont, Novara, Italy.
  • Division of Urology, Department of Oncology, University of Turin, Turin, Italy.
  • Department of Neurosciences, Science of Reproduction and Odontostomatology, University of Naples Federico II, Naples, Italy.
  • Division of Experimental Oncology/Unit of Urology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Vita-Salute San Raffaele University, Milan, Italy.

ORCID-Profile: Michele Nicolazzini, Federico Polverino, Leonardo Quarta, Maximilian Filzmayer, Michele Petix, Calogero Catanzaro, Nick Lee, Jordan A Goyal, Nicola Longo, Felix K H Chun, Carlotta Palumbo, Alessandro Volpe

Zitieren

APA

Nicolazzini, M., Polverino, F., Quarta, L., Filzmayer, M., Petix, M., Catanzaro, C., Lee, N., Goyal, J. A., Longo, N., Musi, G., Chun, F. K. H., Briganti, A., Schiavina, R., Shariat, S. F., Palumbo, C., Volpe, A., Saad, F., & Karakiewicz, P. I. (2026). The effect of time to nephrectomy on cancer‐specific mortality in pathological T stage ( pT)1b –2 renal cancer. BJU International, 138(6), 1160-1170. https://doi.org/10.1111/bju.70468

Vancouver

Nicolazzini M, Polverino F, Quarta L, Filzmayer M, Petix M, Catanzaro C, et al. The effect of time to nephrectomy on cancer‐specific mortality in pathological T stage ( pT)1b –2 renal cancer. BJU International. 2026;138(6):1160-1170. doi:10.1111/bju.70468

BibTeX
@article{Nicolazzini2026,
  author = {Nicolazzini, Michele and Polverino, Federico and Quarta, Leonardo and Filzmayer, Maximilian and Petix, Michele and Catanzaro, Calogero and Lee, Nick and Goyal, Jordan A and Longo, Nicola and Musi, Gennaro and Chun, Felix K H and Briganti, Alberto and Schiavina, Riccardo and Shariat, Shahrokh F and Palumbo, Carlotta and Volpe, Alessandro and Saad, Fred and Karakiewicz, Pierre I},
  title = {The effect of time to nephrectomy on cancer‐specific mortality in pathological T stage ( pT)1b –2 renal cancer},
  journal = {BJU International},
  year = {2026},
  volume = {138},
  number = {6},
  pages = {1160--1170},
  doi = {10.1111/bju.70468}
}
Kostenlos starten →